[1]刘衡,苏红青,杨艳兵,等.高良姜素对大鼠骨髓间充质干细胞成骨分化的影响[J].中国中医骨伤科杂志,2026,34(02):22-27.[doi:10.20085/j.cnki.issn1005-0205.260203]
 LIU Heng,SU Hongqing,YANG Yanbing,et al.The Effect of Galangin on the Osteogenic Differentiation of Rat Bone Marrow Mesenchymal Stem Cells[J].Chinese Journal of Traditional Medical Traumatology & Orthopedics,2026,34(02):22-27.[doi:10.20085/j.cnki.issn1005-0205.260203]
点击复制

高良姜素对大鼠骨髓间充质干细胞成骨分化的影响()

《中国中医骨伤科杂志》[ISSN:1005-0205/CN:42-1340/R]

卷:
第34卷
期数:
2026年02期
页码:
22-27
栏目:
基础研究
出版日期:
2026-02-15

文章信息/Info

Title:
The Effect of Galangin on the Osteogenic Differentiation of Rat Bone Marrow Mesenchymal Stem Cells
文章编号:
1005-0205(2026)02-0022-06
作者:
刘衡1苏红青1杨艳兵1张玉宝1季向南1
1衡水市第二人民医院(河北 衡水,053000)
Author(s):
LIU Heng1SU Hongqing1YANG Yanbing1ZHANG Yubao1JI Xiangnan1
1The Second People's Hospital of Hengshui,Hengshui 053000,Hebei China.
关键词:
高良姜素 大鼠 骨髓间充质干细胞 成骨分化 BMP2/RUNX2通路
Keywords:
galangin rat bone marrow mesenchymal stem cells osteogenic differentiation BMP2/RUNX2 pathway
分类号:
R285.5
DOI:
10.20085/j.cnki.issn1005-0205.260203
文献标志码:
A
摘要:
目的:探究高良姜素对大鼠骨髓间充质干细胞(BMSCs)成骨分化的影响及其作用机制。方法:构建骨质疏松症(OP)大鼠模型并将其分为对照组、模型组、高良姜素低剂量组、高良姜素高剂量组。Micro-CT检测大鼠股骨微结构、qRT-PCR检测股骨组织成骨相关基因(ALP、RUNX2、OPN、BMP2)的相对表达水平。从骨质疏松症大鼠股骨中提取骨髓间充质干细胞并将其分为对照组、高良姜素低剂量组、高良姜素高剂量组、Noggin组、高良姜素高剂量+Noggin组。用CCK-8试剂盒检测细胞活力,用碱性磷酸酶试剂盒检测细胞上清碱性磷酸酶水平,用茜素红染色法检测骨髓间充质干细胞的成骨分化能力; 用Western Blot法检测各组骨髓间充质干细胞中BMP2/RUNX2通路有关蛋白表达量。结果:随着高良姜素剂量的提高,骨质疏松症大鼠骨密度(BMD)、BV/TV、Tb.N、Tb.Th指标水平明显升高,差异有统计学意义(P<0.05)。从骨质疏松症大鼠股骨组织提取的第3代骨髓间充质干细胞生长良好,成骨诱导显示有矿化结节,说明骨髓间充质干细胞提取成功。与对照组相比,随着高良姜素剂量的提高,骨髓间充质干细胞活性增强,细胞上清碱性磷酸酶含量增加,钙化结节增多,BMP2、RUNX2、ALP、OPN、Collagen I蛋白表达水平明显增加,差异有统计学意义(P<0.05); 抑制BMP2/RUNX2通路可明显降低骨髓间充质干细胞活性和细胞上清碱性磷酸酶水平,同时矿化结节数量减少,BMP2、RUNX2、ALP、OPN、Collagen I蛋白表达水平降低,差异有统计学意义(P<0.05); 与高良姜素高剂量组相比,高良姜素高剂量+Noggin组骨髓间充质干细胞活性和细胞上清碱性磷酸酶水平降低,矿化结节数量减少,BMP2、RUNX2、ALP、OPN、Collagen I蛋白表达水平明显减少,差异有统计学意义(P<0.05)。结论:高良姜素可提高骨质疏松症大鼠骨强度,增强骨髓间充质干细胞活性并促进其成骨分化,其潜在机制可能与BMP2/RUNX2通路的激活有关。
Abstract:
Objective:To explore the effect of galangin on osteogenic differentiation of rat bone marrow mesenchymal stem cells(BMSCs)and its mechanism of action.Methods:Osteoporosis(OP)model rats were constructed and assigned to control group,model group,low-dose galangin group,and high-dose galangin group.Micro-CT was used to detect the microstructure of the rat femur,and qRT-PCR was used to detect the relative expression levels of osteogenic-related genes(ALP,RUNX2,OPN,BMP2)in femoral tissue.Bone marrow mesenchymal stem cells(BMSCs)were extracted from the femurs of OP rats and divided into the control group,the low-dose galangin group,the high-dose galangin group,the Noggin group,and the high-dose galangin +Noggin group.CCK-8 assay kit was used to detect cell viability.The ALP assay kit was used to detect ALP in the cell supernatant.The Alizarin Red staining method was performed to detect the osteogenic differentiation ability of BMSCs.Western Blot was performed to detect the BMP2/RUNX2 pathway-related proteins in BMSCs.Results:With the increase of galangin dose,the bone mineral density(BMD),BV/TV,Tb.N,and Tb.Th in OP rats significantly increased(P<0.05).The third-generatio generation BMSCs isolated from femoral tissue of OP rats exhibited good growth,and osteogenic induction resulted in the formation of mineralized nodules,indicating successful extraction of BMSCs.For the control group,as the galangin concentration increased,the activity of BMSCs increased,the ALP level in the cell supernatant increased,the calcified nodules increased,the BMP2,RUNX2,ALP,OPN,and Collagen I proteins significantly increased(P<0.05).Inhibition of the BMP2/RUNX2 pathway clearly reduced the activity of BMSCs and ALP in cell supernatant,reduced mineralized nodules,and decreased BMP2,RUNX2,ALP,OPN,and Collagen I proteins(P<0.05).For the high-dose galangin group,the high-dose galangin+Noggin group showed decreased BMSCs activity and ALP in the cell supernatant,reduced mineralized nodules,and clearly reduced BMP2,RUNX2,ALP,OPN,and Collagen I proteins(P<0.05).Conclusion:Galangin can improve bone strength,enhance BMSCs activity,and promote osteogenic differentiation in OP rats,and its potential mechanism may be related to the activation of the BMP2/RUNX2 pathway.

参考文献/References:

[1] LI H X,XIAO Z S,QUARLES L D,et al.Osteoporosis:mechanism,molecular target and current status on drug development[J].Current Medicinal Chemistry,2021,28(8):1489-1507.
[2] GEHRKE B,ALVES COELHO M C,BRASIL D'ALVA C,et al.Long-term consequences of osteoporosis therapy with bisphosphonates[J].Archives of Endocrinology and Metabolism,2023,68:e220334.
[3] ZENG C Y,WANG S,CHEN F L,et al.Alpinetin alleviates osteoporosis by promoting osteogenic differentiation in BMSCs by triggering autophagy via PKA/mTOR/ULK1 signaling[J].Phytotherapy Research,2023,37(1):252-270.
[4] WANG X D,CHEN T Q,DENG Z H,et al.Melatonin promotes bone marrow mesenchymal stem cell osteogenic differentiation and prevents osteoporosis development through modulating circ_0003865 that sponges miR-3653-3p[J].Stem Cell Research & Therapy,2021,12(1):150.
[5] WANG D B,CHEN J R,PU L,et al.Galangin:a food-derived flavonoid with therapeutic potential against a wide spectrum of diseases[J].Phytotherapy Research,2023,37(12):5700-5723.
[6] WANG X T,XIAO X L.Galangin inhibits lipopolysaccharide-induced inflammation and stimulates osteogenic differentiation of bone marrow mesenchymal stem cells via regulation of AKT/mTOR signaling[J].Allergologia et Immunopathologia,2023,51(1):133-139.
[7] 郭晓彤,宋俊丽,韦秋,等.菟丝子丸调控BMP2/RUNX2信号通路抗绝经后骨质疏松研究[J].天津中医药,2024,41(12):1599-1604.
[8] LI X,ZHOU X J,HUANG Z Y,et al.Study on the mechanism of naringin in promoting bone differentiation:in vitro and in vivo study[J].Heliyon,2024,10(2):e24906.
[9] 康庐琛,魏秋实,李文斌,等.槲皮素调控MAPK通路对绝经后骨质疏松大鼠骨形成的影响[J].中国骨质疏松杂志,2024,30(5):625-630.
[10] 吴永铁,申雄成.高良姜素促进骨质疏松模型大鼠骨折愈合的机制研究[J].中国药房,2023,34(19):2365-2370.
[11] 杨瑜,吴洁,高晓.高良姜素调节SIRT1/AMPK/mTOR信号通路对脂多糖诱导的大鼠关节软骨细胞自噬和凋亡的影响[J].中药新药与临床药理,2024,35(9):1299-1305.
[12] 訾慧,范颖,蒋宁,等.淫羊藿次苷Ⅰ及淫羊藿次苷Ⅱ通过BMP/Runx2/Osx信号通路促进大鼠骨髓间充质干细胞成骨分化的实验研究[J].中国骨质疏松杂志,2019,25(5):690-695.
[13] ZHOU G H,YAN X M,CHEN Z F,et al.ASPN synergizes with HAPLN1 to inhibit the osteogenic differentiation of bone marrow mesenchymal stromal cells and extracellular matrix mineralization of osteoblasts[J].Orthopaedic Surgery,2023,15(9):2423-2434.
[14] CHEN M,HAN H,ZHOU S Q,et al.Morusin induces osteogenic differentiation of bone marrow mesenchymal stem cells by canonical Wnt/β-catenin pathway and prevents bone loss in an ovariectomized rat model[J].Stem Cell Research & Therapy,2021,12(1):173.
[15] ZHANG L,ZHENG Y L,WANG R,et al.Exercise for osteoporosis:a literature review of pathology and mechanism[J].Frontiers in Immunology,2022,13:1005665.
[16] ZHANG F,YAN Y,ZHANG L M,et al.Pharmacological activities and therapeutic potential of galangin,a promising natural flavone,in age-related diseases[J].Phytomedicine,2023,120:155061.
[17] XING Y,ZHANG M S,XIAO J H,et al.Galangin induces the osteogenic differentiation of human amniotic mesenchymal stem cells via the JAK2/STAT3 signaling pathway[J].European Journal of Pharmacology,2022,935:175326.
[18] LEE S H,KIM M,PARK M H.Diphlorethohydroxycamalol isolated from Ishige okamurae prevents H2O2-induced oxidative damage via BMP2/Runx2 signaling in osteoblastic MC3T3-E1 cells[J].Fitoterapia,2021,152:104921.
[19] CHEN Q,YANG Z H,SUN X Y,et al.Inokosterone activates the BMP2 to promote the osteogenic differentiation of bone marrow mesenchymal stem cells and improve bone loss in ovariectomized rats[J].Biochemical and Biophysical Research Communications,2023,682:349-358.
[20] FENG C,XIAO L,YU J C,et al.Simvastatin promotes osteogenic differentiation of mesenchymal stem cells in rat model of osteoporosis through BMP-2/Smads signaling pathway[J].European Review for Medical and Pharmacological Sciences,2020,24(1):434-443.
[21] LI C,LIU X F,CHEN X,et al.Bu-Sui-Dan enhances osteoblast differentiation by upregulating VGLL4 to counteract TEAD4-mediated RUNX2 transcription suppression in ovariectomized rats[J].Journal of Ethnopharmacology,2024,335:118690.
(收稿日期:2025-07-11)

备注/Memo

备注/Memo:
基金项目:衡水市科技计划项目(2022014079Z)
更新日期/Last Update: 2026-02-15